Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
about
Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis CPharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentKASL clinical practice guidelines: management of hepatitis CHepatitis C infection in hemodialysis patients: A reviewInterferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological ResponseDiagnosis, management, and treatment of hepatitis C: an updateIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center studyHepatitis C virus infection and dialysis: 2012 update.Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Successful antiviral triple therapy in a longstanding refractory hepatitis C virus infection with an acute kidney injury.Management of hepatitis C in patients with chronic kidney disease.Hepatitis C and kidney transplantationPegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C.Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipientsMeta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.Management of chronic hepatitis C: consensus guidelines.Hepatitis C virus infection in dialysis patients.SASLT practice guidelines: management of hepatitis C virus infection.Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.SASLT guidelines: Update in treatment of Hepatitis C virus infection.Treatment of chronic hepatitis C in hemodialysis patients.Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review.Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.Viral hepatitis in solid organ transplantation.Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled tAnti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.KASL clinical practice guidelines: management of hepatitis C.Viral hepatitis in hemodialysis: An update2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860
Q24200197-A324BFA4-1F30-47C0-9354-A327595DE6A2Q26751452-5BF80508-A4E2-4B17-B135-2AE4EFC1D89CQ26752471-BF38AB9F-0D05-4DB7-8273-C22933686D26Q27009100-90432820-1471-4480-93FC-B1116442C59AQ27489433-B2B036E7-881F-48D2-82FE-372983CCC597Q29619682-BC44A4B4-D638-4013-B110-588B6A10BBB7Q30375305-CD920A07-FF8D-42C4-AFB5-49A852DF85C0Q30417045-1BD92BA0-9540-42CE-A11F-321272EF27DFQ33434493-966717A4-AAF4-466E-9976-EF732926190AQ33710828-E0BFDEB2-F986-42EA-9D6C-DD902D444834Q33969758-1A1D1C86-BB77-4F1E-928B-3132F85A9F91Q34100370-D33E9501-A3BA-4364-A6E3-4BC81EADDAC2Q34932338-4CF48B25-CECC-44EE-8A52-A90600A99B6EQ35094769-EB24BEED-1FEE-44F6-A1F6-FE7AF9F6F429Q35573744-8BDFE438-0C09-421C-B65E-4310F9466FAFQ35653600-BB315752-65B6-4D2E-A741-AEA511E94F3FQ36642800-E4DCB634-A87B-43B8-A8C9-849A9429897BQ36849347-702118C7-AD5D-46A0-8DE6-F9EEB66465FAQ36852114-BA2C086B-F991-4E34-90DF-11ACBF0E0C8BQ37019765-5DB747A9-916C-4C8D-AE3D-A78CF8871D06Q37174162-46E11E64-E0FE-497E-B955-607C03712724Q37216507-E4AF1D25-DCC5-410B-9056-4E2C7ACB61DCQ37313163-DF3F9A2D-5E48-4F28-A15A-B5D1229690E3Q37335664-FCD02101-B5EB-4332-B152-CB94A12859FDQ37634196-BC790107-BE8F-4401-A1AF-473E7975CD9EQ37812399-13C7C92B-17D1-46D0-882E-DD33CB1BE075Q37831965-F07B97B9-B467-4503-B052-60E4BE7F1F06Q38203823-23EA08E9-BBB1-4F86-8A95-3225E290F851Q38213956-8039D1E5-EBB7-4AD1-ABE9-911480E5A21EQ41750716-8F6EAB85-71A5-48F5-976C-FA2CB328164DQ42267579-5FB083DB-764E-4E05-B20C-997961064993Q42272319-B7B696A0-9A7C-4B27-898C-7581E498CAC2Q42982413-9794241F-586C-42E1-B52F-A6A5B8FAF7C9Q42997177-2ECB39C7-06AC-4ABE-B62B-87DEFF0D1E68Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950Q50556069-5DFC1D48-29D1-4D24-8D46-981B41D5171FQ51836024-0EAD1DAD-3188-40D1-B399-3A0E9E47E887Q56896375-464C36C2-68BB-428A-AB56-4AF0544309BCQ58788714-F37D9BD3-B8FA-46E9-BBEE-94EBEDA3EB56
P2860
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@en
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@nl
type
label
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@en
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@nl
prefLabel
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@en
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
@nl
P2093
P2860
P1476
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
@en
P2093
O Reichard
R Schvarcz
T Carlsson
P2860
P304
P356
10.1111/J.1365-2893.2005.00680.X
P577
2006-05-01T00:00:00Z